- Home
- ARBE vs XBIT Comparison
ARBE vs XBIT Comparison
Compare ARBE & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBE
- XBIT
- Stock Information
- Founded
- ARBE 2015
- XBIT 2005
- Country
- ARBE Israel
- XBIT United States
- Employees
- ARBE N/A
- XBIT N/A
- Industry
- ARBE EDP Services
- XBIT Pharmaceuticals and Biotechnology
- Sector
- ARBE Technology
- XBIT Health Care
- Exchange
- ARBE Nasdaq
- XBIT Nasdaq
- Market Cap
- ARBE 124.2M
- XBIT 105.2M
- IPO Year
- ARBE N/A
- XBIT 2015
- Fundamental
- Price
- ARBE $1.47
- XBIT $2.77
- Analyst Decision
- ARBE Buy
- XBIT
- Analyst Count
- ARBE 2
- XBIT 0
- Target Price
- ARBE $1.75
- XBIT N/A
- AVG Volume (30 Days)
- ARBE 1.2M
- XBIT 61.7K
- Earning Date
- ARBE 05-20-2025
- XBIT 05-20-2025
- Dividend Yield
- ARBE N/A
- XBIT N/A
- EPS Growth
- ARBE N/A
- XBIT N/A
- EPS
- ARBE N/A
- XBIT N/A
- Revenue
- ARBE $768,000.00
- XBIT N/A
- Revenue This Year
- ARBE $398.05
- XBIT N/A
- Revenue Next Year
- ARBE $366.67
- XBIT N/A
- P/E Ratio
- ARBE N/A
- XBIT N/A
- Revenue Growth
- ARBE N/A
- XBIT N/A
- 52 Week Low
- ARBE $0.85
- XBIT $2.65
- 52 Week High
- ARBE $5.09
- XBIT $9.45
- Technical
- Relative Strength Index (RSI)
- ARBE 61.54
- XBIT 41.56
- Support Level
- ARBE $1.30
- XBIT $2.71
- Resistance Level
- ARBE $1.43
- XBIT $3.08
- Average True Range (ATR)
- ARBE 0.09
- XBIT 0.22
- MACD
- ARBE 0.03
- XBIT -0.01
- Stochastic Oscillator
- ARBE 91.67
- XBIT 17.91
About ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, USA, and others.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.